Your search returned 70 results.

Results
	61.	Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials. [electronic resource] by Al-Sawaf, O Robrecht, S Bahlo, J Fink, A M Cramer, P V Tresckow, J Lange, E Kiehl, M Dreyling, M Ritgen, M Dürig, J Tausch, E Schneider, C Stilgenbauer, S Wendtner, C M Fischer, K Hallek, M Eichhorst, B Producer: 20210113 In: Leukemia vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	62.	Hypoxia-induced p38 MAPK activation reduces Mcl-1 expression and facilitates sensitivity towards BH3 mimetics in chronic lymphocytic leukemia. [electronic resource] by Huelsemann, M F Patz, M Beckmann, L Brinkmann, K Otto, T Fandrey, J Becker, H J Theurich, S von Bergwelt-Baildon, M Pallasch, C P Zahedi, R P Kashkar, H Reinhardt, H C Hallek, M Wendtner, C M Frenzel, L P Producer: 20150604 In: Leukemia vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	63.	Fludarabine and cyclophosphamide in combination with alemtuzumab in patients with primary high-risk, relapsed or refractory chronic lymphocytic leukemia. [electronic resource] by Elter, T James, R Busch, R Winkler, D Ritgen, M Böttcher, S Kahl, C Gassmann, W Stauch, M Hasan, I Staib, P Fischer, K Fink, A-M Bahlo, J Bühler, A Döhner, H Wendtner, C-M Stilgenbauer, S Engert, A Hallek, M Producer: 20130212 In: Leukemia vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	64.	Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group. [electronic resource] by Hallek, M Schmitt, B Wilhelm, M Busch, R Kröber, A Fostitsch, H P Sezer, O Herold, M Knauf, W Wendtner, C M Kuse, R Freund, M Franke, A Schriever, F Nerl, C Döhner, H Thiel, E Hiddemann, W Brittinger, G Emmerich, B Producer: 20010927 In: British journal of haematology vol. 114 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	65.	Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab. [electronic resource] by Fink, A M Böttcher, S Ritgen, M Fischer, K Pflug, N Eichhorst, B Wendtner, C-M Winkler, D Bühler, A Zenz, T Staib, P Mayer, J Hensel, M Hopfinger, G Wenger, M Fingerle-Rowson, G Döhner, H Kneba, M Stilgenbauer, S Busch, R Hallek, M Producer: 20131021 In: Leukemia vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	66.	Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib. [electronic resource] by Kazianka, L Drucker, C Skrabs, C Thomas, W Melchardt, T Struve, S Bergmann, M Staber, P B Porpaczy, E Einberger, C Heinz, M Hauswirth, A Raderer, M Pabinger, I Thalhammer, R Egle, A Wendtner, C-M Follows, G Hoermann, G Quehenberger, P Jilma, B Jaeger, U Producer: 20170912 In: Leukemia vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	67.	Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis by the German CLL study group. [electronic resource] by Al-Sawaf, O Robrecht, S Bahlo, J Fink, A M Cramer, P von Tresckow, J Maurer, C Bergmann, M Seiler, T Lange, E Kneba, M Stilgenbauer, S Döhner, H Kiehl, M G Jäger, U Wendtner, C M Fischer, K Goede, V Hallek, M Eichhorst, B Hopfinger, G Producer: 20180601 In: Leukemia vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	68.	Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial. [electronic resource] by Bühler, A Wendtner, C-M Kipps, T J Rassenti, L Fraser, G A M Michallet, A-S Hillmen, P Dürig, J Gregory, S A Kalaycio, M Aurran-Schleinitz, T Trentin, L Gribben, J G Chanan-Khan, A Purse, B Zhang, J De Bedout, S Mei, J Hallek, M Stilgenbauer, S Producer: 20161013 In: Blood cancer journal vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	69.	Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group. [electronic resource] by Hoechstetter, M A Busch, R Eichhorst, B Bühler, A Winkler, D Eckart, M J Vehling-Kaiser, U Schimke, H Jäger, U Hurtz, H J Hopfinger, G Hartmann, F Fuss, H Abenhardt, W Blau, I Freier, W Müller, L Goebeler, M Wendtner, C M Bahlo, J Fischer, K Bentz, M Emmerich, B Döhner, H Hallek, M Stilgenbauer, S Producer: 20180604 In: Leukemia vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	70.	Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. [electronic resource] by Hallek, M Fischer, K Fingerle-Rowson, G Fink, A M Busch, R Mayer, J Hensel, M Hopfinger, G Hess, G von Grünhagen, U Bergmann, M Catalano, J Zinzani, P L Caligaris-Cappio, F Seymour, J F Berrebi, A Jäger, U Cazin, B Trneny, M Westermann, A Wendtner, C M Eichhorst, B F Staib, P Bühler, A Winkler, D Zenz, T Böttcher, S Ritgen, M Mendila, M Kneba, M Döhner, H Stilgenbauer, S Producer: 20101019 In: Lancet (London, England) vol. 376 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)